RxDoctor Payments Data

Jabin Krassin

Ophthalmology · Hastings, MNNPI 1801092960

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (44.8%), consulting fees and speaking fees — rather than concentrated in one kind of arrangement. Glaukos Corporation accounts for 63.8% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2022 at $6,654 and has fallen 81.2% since, to $1,250 in 2025. Among ophthalmology clinicians in MN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$16,734in general payments, 2019–2025

Across 136 payments — averaging $123.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Glaukos Corporation$11K
  • Alcon$5K
  • Sight Sciences, Inc.$686
  • Biotissue Holdings Inc.$192
  • AbbVie$80
  • The Cameron-ehlen Group, Inc.$29
  • plus $42 from 2 others
$178,430in research payments, 2019–2025

Across 102 payments — averaging $1749.31 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Glaukos Corporation$151K
  • Biotissue Holdings Inc.$27K

What the payments were for

  • Consulting fees$5,13031%
  • Speaking & faculty fees$2,50015%
  • Travel & lodging$1,61010%
  • Food & beverage$7,49445%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Glaukos Corporation45$10,673
Alcon71$5,031
Sight Sciences, Inc.8$686
Biotissue Holdings Inc.5$192
AbbVie(2 entities)3$80
The Cameron-ehlen Group, Inc.2$29
Rxsight Inc1$26
Apellis Pharmaceuticals, Inc.1$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$16,734 in reported general payments places this provider in the 95th percentile of 330 ophthalmology providers in Minnesota.

See all ophthalmology providers in Minnesota

Medicare billing

Part B allowed, 2024
$176,079
Medicare patients
187
Services billed
1,136

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Prednisolone Acetate99$3,591
Latanoprost64$769
Tobramycin-DexamethasoneTobramycin/Dexamethasone14$612
Ketorolac Tromethamine31$475
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat27$473
Dorzolamide Hcl20$342
ErythromycinErythromycin Base28$249
MoxifloxacinMoxifloxacin Hcl20$246
Timolol Maleate21$174

Paid to pharmacies, not to this prescriber.

Other ophthalmology in Hastings

See the full list for Minnesota

Where these figures come from

Is this you, or does something look wrong? →